Skip to content
10-K

Annual Report

ROCK CREEK PHARMACEUTICALS, INC.

0001144204-16-089559

← back to feed
Filed
Mar 22, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Mar 2, 2016 11.98M sh
Capex FY 2015 · Dec 31, 2015 $8K
Capex FY 2015 · Dec 31, 2014 $218K
Long Term Debt FY 2015 · Dec 31, 2015 $8M
Long Term Debt FY 2015 · Dec 31, 2014 $350K
Short Term Debt FY 2015 · Dec 31, 2015 $12.35M
Short Term Debt FY 2015 · Dec 31, 2014 $0
Cash And Equivalents FY 2015 · Dec 31, 2015 $493K
Cash And Equivalents FY 2015 · Dec 31, 2014 $395K
Cash And Equivalents FY 2015 · Dec 31, 2013 $3.88M
Stockholders Equity FY 2015 · Dec 31, 2015 −$10.65M
Stockholders Equity FY 2015 · Dec 31, 2014 −$10.84M
Stockholders Equity FY 2015 · Dec 31, 2013 $6.98M
Current Liabilities FY 2015 · Dec 31, 2015 $22.19M
Current Liabilities FY 2015 · Dec 31, 2014 $19.4M
Total Liabilities FY 2015 · Dec 31, 2015 $30.19M
Total Liabilities FY 2015 · Dec 31, 2014 $19.75M
Current Assets FY 2015 · Dec 31, 2015 $1.04M
Current Assets FY 2015 · Dec 31, 2014 $7.8M
Total Assets FY 2015 · Dec 31, 2015 $19.55M
Total Assets FY 2015 · Dec 31, 2014 $8.92M
Sga Expense FY 2015 · Dec 31, 2015 $8.83M
Sga Expense FY 2015 · Dec 31, 2014 $28.97M
Rd Expense FY 2015 · Dec 31, 2015 $2.49M
Rd Expense FY 2015 · Dec 31, 2014 $3.61M
Net Income FY 2015 · Dec 31, 2015 −$6.85M
Net Income FY 2015 · Dec 31, 2014 −$38.52M
Operating Income FY 2015 · Dec 31, 2015 −$11.32M
Operating Income FY 2015 · Dec 31, 2014 −$32.58M
Gross Profit FY 2015 · Dec 31, 2015 $0
Gross Profit FY 2015 · Dec 31, 2014 $0
Cost Of Revenue FY 2015 · Dec 31, 2015 $0
Cost Of Revenue FY 2015 · Dec 31, 2014 $0